Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Feb 27, 2024; 16(2): 146-151
Published online Feb 27, 2024. doi: 10.4254/wjh.v16.i2.146
Changes in the etiology of liver cirrhosis and the corresponding management strategies
Jin-Jin Dai, Yue-Ying Liu, Zhen-Hua Zhang
Jin-Jin Dai, Department of Infectious Diseases, Suzhou Hospital of Anhui Medical University, Suzhou 234000, Anhui Province, China
Jin-Jin Dai, Yue-Ying Liu, Zhen-Hua Zhang, Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, Anhui Province, China
Author contributions: Dai JJ and Liu YY contributed to this paper; Zhang ZH designed the overall concept and outline of the manuscript; Liu YY contributed to the discussion and design of the manuscript; Dai JJ contributed to the writing, and editing the manuscript, illustrations, and review of literature.
Supported by Anhui Provincial Natural Science Foundation, No. 2108085MH298; University Scientific Research Project of Anhui Provincial Education Department, No. KJ2021A0323; Fund of Anhui Medical University, No. 2021xkj196; and Clinical Medicine Project of Anhui Medical University, No. 2021LCXK027.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zhen-Hua Zhang, MD, PhD, Professor, Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, No. 678 Furong Road, Hefei 230601, Anhui Province, China. zzh1974cn@163.com
Received: December 10, 2023
Peer-review started: December 10, 2023
First decision: January 15, 2024
Revised: January 16, 2024
Accepted: January 30, 2024
Article in press: January 30, 2024
Published online: February 27, 2024
Processing time: 78 Days and 21.6 Hours
Abstract

We read with interest the article by Xing Wang, which was published in the recent issue of the World Journal of Hepatology 2023; 15: 1294-1306. This article focuses particularly on the prevalence and trends in the etiology of liver cirrhosis (LC), prognosis for patients suffering from cirrhosis-related complications and hepatocellular carcinoma (HCC), and management strategies. The etiology of cirrhosis varies according to geographical, economic, and population factors. Viral hepatitis is the dominant cause in China. Vaccination and effective treatment have reduced the number of people with viral hepatitis, but the overall number is still large. Patients with viral hepatitis who progress over time to LC and HCC remain an important population to manage. The increased incidence of metabolic syndrome and alcohol consumption is likely to lead to a potential exponential increase in metabolic dysfunction-associated steatotic liver disease (MASLD)-associated LC and alcoholic liver disease in the future. Investigating the evolution of the etiology of LC is important for guiding the direction of future research and policy development. These changing trends indicate a need for greater emphasis on tackling obesity and diabetes, and implementing more effective measures to regulate alcohol consumption in order to reduce the occurrence of MASLD. In an effort to help cope with these changing trends, the authors further proposed countermeasures for healthcare authorities doctors, and patients.

Keywords: Liver cirrhosis; Etiology; Viral hepatitis; Alcoholic liver disease; Hepatocellular carcinoma; Metabolic dysfunction-associated steatotic liver disease

Core Tip: China is aiming to eradicate viral hepatitis as a public health threat by 2030. It is expected that the prevalence of viral hepatitis will decrease in the coming years. The increasing prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) may emerge as a leading cause of liver cirrhosis. Additionally, excessive alcohol consumption is a significant risk factor. These shifting trends necessitate innovative management strategies. There is a need for sustained implementation of measures to eliminate viral hepatitis, as well as greater efforts to control obesity, diabetes and alcohol consumption to reduce the incidence of MASLD and Alcoholic liver disease.